An expert consultation process for a domestic license review for AstraZeneca’s corona vaccine, which has been approved for conditional sale by the European Commission, begins.
The Ministry of Food and Drug Safety held a meeting of the’Corona 19 Vaccine Verification Advisory Group’ in which external experts participate today (31st) to discuss the safety and effectiveness of AstraZeneca vaccine and the appropriateness of target patients.
Recently, Germany has been controversial as AstraZeneca vaccine has not been sufficiently clinically tested in people over 65 years of age, and limits vaccinations to the elderly.
The Ministry of Food and Drug Safety said, “There is no established conclusion regarding vaccination for the elderly,” and said the results of the advisory group meeting will be released tomorrow (1st).
<사진=연합뉴스>
–
Provision of articles and press releases [email protected] / copyrightⓒ tbs. Unauthorized reproduction & redistribution prohibited
